Citation: Ginat DT, Saad W, Kitanono T. Balloon-Occluded Retrograde Transvenous Obliteration of a GastroRenal Shunt using Hydrogel-Coated Coil Embolization. Radiology Case Reports. [Online] 2009;4:290.
Copyright: © 2009 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License, which permits reproduction and distribution, provided the original work is properly cited. Commercial use and derivative works are not permitted.
Abbreviations: BRTO, balloon-occluded retrograde transvenous obliteration; CT, computed tomography
Daniel T. Ginat, M.D., M.S. (Email: email@example.com), Wael Saad M.D., and Takashi Kitanono, M.D., are in the Department of Imaging Sciences and Interventional Radiology, University of Rochester Medical Center, Rochester New York, United States of America.
Published: July 16, 2009
Balloon-retrograde transvenous obliteration (BRTO) can be an appropriate treatment modality for hepatic encephalopathy in the setting of portal-systemic shunting in selected patients. We describe a case of a large gastro-renal shunt that was successfully treated via combined BRTO and expandable hydrogel-coated coil embolization, with an emphasis on technique.
Balloon-occluded retrograde transvenous obliteration (BRTO) is indicated for treatment for gastric varices with gastro-renal shunts at some institutions [1-5]. The technique involves injecting gastric varices with 5% ethanolamine oleate iopamidol for 30 minutes via a balloon catheter, while occluding the gastro-systemic shunt [1,2]. In certain conditions, such as in the presence of fundal gastric varices, standard BRTO is not effective. In addition, portal hypertensive changes, such as ascites and splenomegaly, can be aggravated shortly after BRTO in up to 82% of patients . Instead, modified BRTO techniques may be more appropriate. These include stepwise injection of the sclerosing agent, selective injection of the agent via a microcatheter, coil embolization of the afferent gastric veins, double-balloon catheterization, and BRTO with percutaneous transhepatic portal venous access or transileocolic venous access [1,2,7]. Auxiliary procedures such as infusion of 50% glucose solution into collateral vessels can improve the outcome of BRTO . Perhaps the most significant complication of BRTO is the development of esophageal varices [9,10].
In this report, we describe the technique for treatment of gastric varices and gastro-splenic shunt in via BRTO in conjunction and expandable hydrogel coil embolization.
A 60-year-old man with a history of end-stage liver disease secondary to hepatitis C, status post orthotopic liver transplant 15 years ago, presented with mental status changes attributed to hepatic encephalopathy. The encephalopathy was refractory to lactulose and rifaximin therapy.
CT of the abdomen revealed an enlarged left renal vein and a complex of gastric varices, suggesting gastro-renal shunting (Fig. 1). Consequently, percutaneous embolization of the shunt was requested.
Figure 1. 60-year-old man with hepatic encephalopathy. Axial CT demonstrates multiple gastric varices (arrow).
A Seldinger's needle was advanced into the right femoral vein and a 035 Rosen wire was inserted. An 8 French sheath was then inserted over the wire. A 5 French C2 catheter was inserted over the wire and the left renal vein was selected. A 035 glidewire was then advanced into the gastro-renal shunt. The catheter was advanced into the shunt and the wire was exchanged to a Rosen wire again. A 5 French balloon catheter was then advanced over the wire into the outflow vein of the shunt. A retrograde venogram was obtained while the outflow tract was occluded with the balloon (Fig. 2). The outflow vein was partially visualized. A microcatheter could not be advanced through the balloon catheter so a second puncture was made in the right groin. A 5 French sheath was inserted using a similar technique. A 035 C2 catheter was advanced into the renal vein. A Renegade microcatheter was then advanced through the catheter past the balloon into the shunt using 014 Transcend wire. The shunt was coiled using 6 Azure hydrogel detachable coils (Terumo, Somerset, N.J.). After approximately 15 minutes, complete occlusion of the shunt was observed (Fig. 3). There were no immediate complications and the patient’s symptoms improved.
Figure 2. 60-year-old man with hepatic encephalopathy. Digital subtraction angiogram shows a 5 French balloon catheter inflated within the outflow tract.
Figure 3. 60-year-old man with hepatic encephalopathy. A subsequent digital subtraction angiogram demonstrates coils inserted proximal to the gastro-renal shunt outflow tract, providing complete occlusion.
BRTO has been shown to be suitable treatment option for portal-systemic encephalopathy secondary extrahepatic portal-systemic shunts, including gastro-renal, spleno-renal, and mesenteric-renal shunts in patients with and without liver cirrhosis [9-13]. Complete occlusion of portal-systemic shunts can be achieved using sclerosing agent injection [9,10,12]. It is essential to demonstrate under venography that portal venous flow redirected to the liver during the balloon occlusion.
In patients with gastric varices and hepatic encephalopathy, 1 and 3-year relapse-free survival rates of over 90% and 87%, respectively, have been reported with BRTO . Good results have also been achieved by combining BRTO with embolic coils inserted via the renal vein, similar to our case . However, our case is the first reported instance of use of expandable hydrogel coils for gastro-renal shunt occlusion. The advantage of this type of coil is that it can expand to several times its diameter, enhancing the extent of thrombosis. Therefore, this technique allows the use of fewer coils. Indeed, the hydrogel coil polymer provides about 5 times more filling volume for the 0.018" coil and 4 times more filling volume for the 0.035" coil compared to conventional coils.
BRTO in combination with self-expandable coil embolization can achieve satisfactory occlusion of gastro-renal shunts and immediate clinical improvement in patients with hepatic encephalopathy. Although not observed in our case, there is the theoretical risk of coil migration following balloon deflation. Therefore, additional experience and caution with this technique is warranted.
1. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics. 2003 Jul-Aug;23(4):921-37; discussion 937. [PubMed]
2. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics. 2003 Jul-Aug;23(4):911-20. [PubMed]
3. Kameda N, Higuchi K, Shiba M, Kadouchi K, Machida H, Okazaki H, Tanigawa T, Watanabe T, Tominaga K, Fujiwara Y, Nakamura K, Arakawa T. Management of gastric fundal varices without gastro-renal shunt in 15 patients. World J Gastroenterol. 2008 Jan 21;14(3):448-53. [PubMed]
4. Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol. 2006 Jun 28;12(24):3866-73. [PubMed]
5. Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003 Apr-Jun;4(2):109-16. [PubMed]
6. Cho SK, Shin SW, Yoo EY, Do YS, Park KB, Choo SW, Han H, Choo IW. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol. 2007 Nov-Dec;8(6):520-30. [PubMed]
7. Fukatsu H, Kawamoto H, Harada R, Tsutsumi K, Fujii M, Kurihara N, Ogawa T, Ishida E, Okamoto Y, Okada H, Sakaguchi K. Gastric fundal varices with an exposed microcoil after the combined BRTO and PTO therapy. Endoscopy. 2007 Feb;39 Suppl 1:E247-8. [PubMed]
8. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration. Australas Radiol. 2007 Aug;51(4):334-8. [PubMed]
9. Tanaka O, Ishihara K, Oyamada H, Harusato A, Yamaguchi T, Ozawa M, Nakano K, Yamagami T, Nishimura T. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis. J Vasc Interv Radiol. 2006 Dec;17(12):1951-5. [PubMed]
10. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001 Mar;12(3):327-36. [PubMed]
11. Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):121-5. [PubMed]
12. Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H.Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Intern Med. 2001 Aug;40(8):688-91. [PubMed]
13. Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):121-5. [PubMed]
14. Yokoyama S, Kasahara M, Fukuda A, Uemoto S, Nosaka S. Balloon-occluded retrograde transvenous obliteration in a patient with hyperammonemic encephalopathy after living donor liver transplantation. Liver Transpl. 2007 Aug;13(8):1201-2. [PubMed]
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License.
Call For Papers
Radiology Case Reports began publication in January, 2006. We invite you to support the first peer-reviewed journal established specifically to publish case reports in radiology by submitting case report manuscripts for publication.
To submit a case for review, first register with the site as an author (there is no charge for this). When you log in as an author, you will be guided through the submission process.